Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICOSAPENT ETHYL for very high triglycerides (China Phase 3)
CTR20170362Phase 3Completed
- Sponsor
- Amarin Corporation plc
- Start
- Aug 2017
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in hypertriglyceridemia, sponsored by Amarin Corporation plc. Started Aug 2017; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on CTR20170362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170362.